Riskpilot← Back to searchSign inGet full accessLifemed Group Oy
OYActiveY-tunnus 2515260-9Billskogintie 19-KActivities of head offices · NACE 7010Est. 20124 employees
Revenue 2025
EUR 514K
-4% vs 2024
EBITDA margin
11.6%
-59% vs 2024
Equity ratio
96.5%
Financial strength
Net profit 2025
EUR 114K
-22% vs 2024
| Revenue | EUR 514K | -4% |
| EBITDA | EUR 60K | -59% |
| Net profit | EUR 114K | -22% |
| Total assets | EUR 2,2M | -3% |
| Equity | EUR 2,1M | -3% |
| Employees | 4 | — |
Legal name
Lifemed Group Oy
Y-tunnus number
2515260-9
Legal form
Osakeyhtiö
NACE code
7010 · Activities of head offices
Founded
29. marraskuuta 2012
Share capital
EUR 2 500
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on tarjota johto-, hallinnointi-, kehitys-, talous-, IT- ja rahoituspalveluita konsernin muille yhtiöille sekä toimia konsernin emoyhtiönä. Yhtiö voi myös omistaa ja hallita arvopapereita, rakennuksia ja kiinteistöjä ja käydä niillä kauppaa tai vuokrata niitä.
Address
Billskogintie 19-K
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 497 | 524 | 529 | 537 | 514 |
| Staff expenses | −263 | −260 | −267 | −270 | −285 |
| EBITDA | 90 | 153 | 143 | 144 | 60 |
| Depreciation & amort. | −50 | −25 | −14 | −10 | −6 |
| EBIT | 39 | 128 | 129 | 135 | 54 |
| Net financials | 124 | 75 | 92 | 40 | 73 |
| Profit before tax | 163 | 203 | 221 | 175 | 127 |
| Tax | 8 | 26 | 28 | 29 | 12 |
| Net profit | 155 | 177 | 193 | 146 | 114 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 260 | 2 253 | 2 289 | 2 251 | 2 183 |
| Equity | 2 122 | 2 129 | 2 169 | 2 166 | 2 107 |
| Long-term debt | 53 | 35 | 16 | 0 | 0 |
| Short-term debt | 85 | 88 | 103 | 85 | 76 |
| Total debt | 138 | 124 | 120 | 85 | 76 |
EBITDA margin
11.6%
This company
15.8%
Market median
-27% vs market
20212025
Equity ratio
96.5%
This company
38.2%
Market median
+153% vs market
20212025
Return on equity
5.4%
This company
18.4%
Market median
-71% vs market
20212025
Net profit margin
22.2%
This company
8.1%
Market median
+174% vs market
20212025
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TH Deputy Member | Deputy Member | 2016 |
TJ Chief Executive Officer | Chief Executive Officer | 2012 |
| Former (1) | ||
MH Audit | Audit | 2018 – 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lifemed Group Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mikko Henrikki Luoma | Audit | 0 companies |
| Timo Heikki Olavi Lipasti | Deputy Member | 0 companies |
| Turo Juhani Linnala | Chief Executive Officer | 0 companies |